One of the cruel features of Alzheimer's disease is the way it spreads, creeping from region to region across the brain. Now scientists believe they have found a key part of how it travels — and, with it, a possible point of attack.
A hijacked messenger
The work, reported by Science Daily and carried out by researchers at the University of Utah Health, centers on a protein called Arc. In a healthy brain, Arc helps neurons communicate, ferrying molecular messages between cells inside tiny membrane bubbles. The new study, published in the journal Cell, found that the toxic protein tau — which clumps into the tangles that kill neurons in Alzheimer's — hitches a ride inside those same Arc-carried bubbles, traveling from sick cells to healthy ones and seeding the disease as it goes.
What the experiments showed
In mice engineered to develop Alzheimer's-like changes, removing the Arc gene cut the spread of tau between neurons almost entirely, the team found. Crucially, the researchers also saw signs of the same Arc–tau mechanism in samples of human brain tissue — an important check, since results in mice do not always hold true in people.
Not a simple villain
The findings come with a twist that matters for any future treatment. Arc is not purely harmful: it also appears to help ailing cells dispose of excess toxic tau, and when the researchers blocked it completely, neurons died faster, not slower. That argues against simply switching Arc off. Instead, the team suggests a more targeted approach — intercepting the tau-laden bubbles in transit between cells, while leaving Arc's protective role intact.
Promising, but early
Experts have long sought ways to halt Alzheimer's progression rather than merely ease its symptoms, and a mechanism for how the disease physically spreads offers a fresh set of targets beyond the amyloid plaques that have dominated drug development. The disease affects an estimated 55 million people worldwide.
But the researchers were careful to stress how far this is from a treatment. Most of the work was done in mice, and turning a laboratory insight into a therapy that is safe and effective in humans typically takes many years, if it succeeds at all. For now, the discovery is best understood as a new and promising lead — a map of one of the roads the disease travels, and a hint at how it might one day be blocked.
